AU2002322802A1 - Thrombin inhibitors - Google Patents
Thrombin inhibitorsInfo
- Publication number
- AU2002322802A1 AU2002322802A1 AU2002322802A AU2002322802A AU2002322802A1 AU 2002322802 A1 AU2002322802 A1 AU 2002322802A1 AU 2002322802 A AU2002322802 A AU 2002322802A AU 2002322802 A AU2002322802 A AU 2002322802A AU 2002322802 A1 AU2002322802 A1 AU 2002322802A1
- Authority
- AU
- Australia
- Prior art keywords
- thrombin inhibitors
- thrombin
- inhibitors
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30829801P | 2001-07-27 | 2001-07-27 | |
| US60/308,298 | 2001-07-27 | ||
| PCT/US2002/024219 WO2003011222A2 (en) | 2001-07-27 | 2002-07-23 | Thrombin inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2002322802A1 true AU2002322802A1 (en) | 2003-02-17 |
Family
ID=23193395
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002322802A Abandoned AU2002322802A1 (en) | 2001-07-27 | 2002-07-23 | Thrombin inhibitors |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2002322802A1 (en) |
| WO (1) | WO2003011222A2 (en) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20071132A1 (en) * | 2005-12-23 | 2007-12-14 | Bristol Myers Squibb Co | MACROCYCLIC COMPOUNDS AS INHIBITORS OF FACTOR VIIA |
| PE20081775A1 (en) * | 2006-12-20 | 2008-12-18 | Bristol Myers Squibb Co | MACROCYCLIC COMPOUNDS AS INHIBITORS OF FACTOR VIIA |
| TW201311689A (en) | 2011-08-05 | 2013-03-16 | 必治妥美雅史谷比公司 | Novel macrocycles as factor XIa inhibitors |
| TW201319068A (en) * | 2011-08-05 | 2013-05-16 | 必治妥美雅史谷比公司 | Cyclic P1 linkers as factor XIa inhibitors |
| KR101937514B1 (en) | 2011-10-14 | 2019-01-10 | 브리스톨-마이어스 스큅 컴퍼니 | Substituted tetrahydroisoquinoline compounds as factor xia inhibitors |
| WO2014059202A1 (en) | 2012-10-12 | 2014-04-17 | Bristol-Myers Squibb Company | Guanidine substituted tetrahydroisoquinoline compounds as factor xia inhibitors |
| EP2906551B1 (en) | 2012-10-12 | 2018-02-28 | Bristol-Myers Squibb Company | Crystalline forms of a factor xia inhibitor |
| WO2014059214A1 (en) | 2012-10-12 | 2014-04-17 | Bristol-Myers Squibb Company | Guanidine and amine substituted tetrahydroisoquinoline compounds as factor xia inhibitors |
| JP6479763B2 (en) | 2013-03-25 | 2019-03-06 | ブリストル−マイヤーズ スクイブ カンパニーＢｒｉｓｔｏｌ−Ｍｙｅｒｓ Ｓｑｕｉｂｂ Ｃｏｍｐａｎｙ | Substituted azole containing tetrahydroisoquinolines as factor XIA inhibitors |
| US20170002006A1 (en) * | 2014-01-31 | 2017-01-05 | Bristol-Myers Squibb Company | Macrocycles with hetrocyclic p2' groups as factor xia inhibitors |
| NO2760821T3 (en) | 2014-01-31 | 2018-03-10 | ||
| ES2714283T3 (en) | 2014-09-04 | 2019-05-28 | Bristol Myers Squibb Co | Macrocycles of diamide that are inhibitors of FXIa |
| US9453018B2 (en) | 2014-10-01 | 2016-09-27 | Bristol-Myers Squibb Company | Pyrimidinones as factor XIa inhibitors |
| EP3319969B1 (en) * | 2015-07-06 | 2024-04-03 | Turning Point Therapeutics, Inc. | Diaryl macrocycle polymorph |
-
2002
- 2002-07-23 AU AU2002322802A patent/AU2002322802A1/en not_active Abandoned
- 2002-07-23 WO PCT/US2002/024219 patent/WO2003011222A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003011222A3 (en) | 2004-03-18 |
| WO2003011222A2 (en) | 2003-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002250394A1 (en) | Rho-kinase inhibitors | |
| AU2002245709A1 (en) | Rho-kinase inhibitors | |
| AU2001258771A1 (en) | -secretase inhibitors | |
| AU2003202263A1 (en) | Roh-kinase inhibitors | |
| AU2002367773A1 (en) | Fab i inhibitors | |
| AU2002211663A1 (en) | Nf-$g(k)b inhibitors | |
| AU2001294557A1 (en) | Thrombin inhibitors | |
| AU2003249683A1 (en) | Nf-:b inhibitors | |
| AU2001247589A1 (en) | Non-amidine containing protease inhibitors | |
| AU2002322802A1 (en) | Thrombin inhibitors | |
| AU2003299901A1 (en) | Thrombin inhibitors | |
| AU2003269984A1 (en) | Protease inhibitors | |
| AU2002351076A1 (en) | Thrombin inhibitors | |
| AU2001255408A1 (en) | Tetrahydro-azepinone derivatives as thrombin inhibitors | |
| AU2002360673A1 (en) | Gp41 inhibitor | |
| AU2001278997A1 (en) | Thrombin inhibitors | |
| AU2002342682A1 (en) | Protease inhibitors | |
| AU2001265094A1 (en) | Pyrazinone thrombin inhibitors | |
| AU2003263738A1 (en) | Protease inhibitors | |
| AU2002246675A1 (en) | Thrombin inhibitors | |
| AU2002334846A1 (en) | Elastase inhibitors | |
| AU2002305868A1 (en) | Inhibitors of reggamma | |
| GB0109278D0 (en) | Enzyme inhibitors | |
| AU2002363791A1 (en) | Protease enzyme inhibitors | |
| AU2002247158A1 (en) | Thrombin inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |